Investors Seek GLP-1 Alternatives After Nausea Hurdles
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
We evaluate long-term return potential across index funds to help you identify candidates with the strongest growth prospects.
28,522 articlesA new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
MercadoLibre's fourth-quarter results showed strong revenue growth, but a notable drop in profitability. This article...
Three u.s. military service members were killed in an Iran operation, CENTCOM says. The move sent ripples through ene...
Mortgage rates move higher for a second straight week, delaying any spring surge in activity. Analysts say inflation ...
When a top bank places a stock on its conviction list, it moves markets. This article explains why Goldman Sachs just...
As inflation erodes purchasing power, a decades-old rule could push a larger portion of retirement income into taxabl...
Today’s pullback in microsoft stock sinking today has investors scanning headlines for AI, policy, and growth signals...
A draft tax package for digital assets circulates ahead of a House Ways and Means hearing next week. It would require...
Early indicators point to a modest 2027 social security cola, around 2.8%, but higher Medicare premiums could erode t...
Bitcoin just dropped below 60K, prompting a careful look at what happens next. This guide uses historical patterns to...
SpaceX plans a record-breaking IPO, but the bulk of proceeds is already spoken for. Analysts warn the small public fl...
A high-profile NDA with multi-million-dollar penalties has put personal finances in the spotlight. This guide breaks ...